Clinical Outcomes Improvement Committee

Purpose:
The Clinical Outcomes Improvement Committee assists hematopoietic progenitor cell transplant programs with improving patient outcomes by providing resources, creating tools, and reviewing corrective action plans.

Current members of Clinical Outcomes Improvement Committee:

Position

Name

Organization

City

Country

Chair

C. Fred LeMaistre MD

Nashville

United States

Vice-Chair

Dr. Luke Akard MD

Indiana Blood and Marrow Transplantation (IBMT)

Indianapolis

United States

Member

Ahmad Samer Al-Homsi MD

NYU Langone Health Hematopoietic Progenitor Cell Transplant Program

New York

United States

Member

Dennis Gastineau MD

The Blood and Marrow Transplant Program at Mayo Clinic Arizona and Phoenix Children's Hospital

Phoenix

United States

Member

Kamar Godder MD, MPH

Nicklaus Children's Hospital Blood and Marrow Transplant Program

Miami

United States

Member
Chair of ASBMT Quality Outcomes Committee

Mark Juckett MD

University of Wisconsin Madison Hematopoietic Stem Cell Program

Madison

United States

Member

George Selby MD

The OU Medical Center Blood and Marrow Transplant Program

Oklahoma City

United States

Member

Amir Steinberg MD, FACP

Mount Sinai Bone Marrow and Stem Cell Transplantation Program

New York City

United States

Member

Phyllis Warkentin MD

Biologics Production Facility, Nebraska Medicine, The Nebraska Medical Center

Omaha

United States

Staff Liaison

Kara Wacker MBA, RAC

Foundation for the Accreditation of Cellular Therapy

Omaha

United States


Ask FACT

FAQ

As a Matter of FACT

FACT inspectors have free access to all FACT training and educational opportunities.